Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pasireotide LAR in Severe Polycystic Liver Disease (SOM230)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Marie Hogan, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01670110
First received: August 17, 2012
Last updated: September 6, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)